Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2018.1439474
Abstract: ABSTRACT Objective: In this pharmacovigilance study, we aimed to determine the incidence of spontaneously reported suspected adverse drug reactions (ADRs) related to oral anticoagulants: non-vitamin K antagonist oral anticoagulants (NOACs; apixaban, dabigatran, edoxaban, rivaroxaban) and… read more here.
Keywords: drug; pharmacovigilance study; oral anticoagulants; suspected adverse ... See more keywords
P1591Cardiovascular toxicity of ibrutinib: a pharmacovigilance study
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz748.0350
Abstract: Ibrutinib, a first in class Bruton tyrosine kinase inhibitor, has revolutionized treatment for several B-cell malignancies. However, early data suggested that ibrutinib was associated with supra-ventricular arrhythmias (SVA) and bleeding. Other types of cardiovascular adverse… read more here.
Keywords: ibrutinib; ror ic025; pharmacovigilance study; days iqr ... See more keywords